- Home
- IMMP vs TKNO Comparison
IMMP vs TKNO Comparison
Compare IMMP & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- TKNO
- Stock Information
- Founded
- IMMP 1987
- TKNO 1996
- Country
- IMMP Australia
- TKNO United States
- Employees
- IMMP N/A
- TKNO N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- IMMP Health Care
- TKNO Health Care
- Exchange
- IMMP Nasdaq
- TKNO Nasdaq
- Market Cap
- IMMP 251.8M
- TKNO 256.9M
- IPO Year
- IMMP N/A
- TKNO 2021
- Fundamental
- Price
- IMMP $1.76
- TKNO $4.75
- Analyst Decision
- IMMP Buy
- TKNO
- Analyst Count
- IMMP 1
- TKNO 0
- Target Price
- IMMP $7.00
- TKNO N/A
- AVG Volume (30 Days)
- IMMP 79.3K
- TKNO 265.1K
- Earning Date
- IMMP 10-21-2025
- TKNO 08-07-2025
- Dividend Yield
- IMMP N/A
- TKNO N/A
- EPS Growth
- IMMP N/A
- TKNO N/A
- EPS
- IMMP N/A
- TKNO N/A
- Revenue
- IMMP $3,019,249.00
- TKNO $38,923,000.00
- Revenue This Year
- IMMP $50.37
- TKNO $8.73
- Revenue Next Year
- IMMP N/A
- TKNO $16.53
- P/E Ratio
- IMMP N/A
- TKNO N/A
- Revenue Growth
- IMMP 24.11
- TKNO 11.40
- 52 Week Low
- IMMP $1.32
- TKNO $4.00
- 52 Week High
- IMMP $2.72
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- IMMP 52.82
- TKNO 52.61
- Support Level
- IMMP $1.63
- TKNO $4.28
- Resistance Level
- IMMP $1.85
- TKNO $4.78
- Average True Range (ATR)
- IMMP 0.07
- TKNO 0.40
- MACD
- IMMP -0.01
- TKNO 0.03
- Stochastic Oscillator
- IMMP 52.08
- TKNO 49.66
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.